Institute of Medical Physics, School of Physics, University of Sydney, NSW, Australia.
J Appl Clin Med Phys. 2013 May 6;14(3):4085. doi: 10.1120/jacmp.v14i3.4085.
Cone-beam computed tomography (CBCT) is used for external-beam radiation therapy setup and target localization. As with all medical applications of ionizing radiation, radiation exposure should be managed safely and optimized to achieve the necessary image quality using the lowest possible dose. The present study investigates doses from standard kilovoltage kV radiographic and CBCT imaging protocol, and proposes two novel reduced dose CBCT protocols for the setup of breast cancer patients undergoing external beam radiotherapy. The standard thorax kV and low-dose thorax CBCT protocols available on Varian's On-Board Imaging system was chosen as the reference technique for breast imaging. Two new CBCT protocols were created by modifying the low-dose thorax protocol, one with a reduced gantry rotation range ("Under breast" protocol) and the other with a reduced tube current-time product setting ("Low dose thorax 10ms" protocol). The absorbed doses to lungs, heart, breasts, and skin were measured using XRQA2 radiochromic film in an anthropomorphic female phantom. The absorbed doses to lungs, heart, and breasts were also calculated using the PCXMC Monte Carlo simulation software. The effective dose was calculated using the measured doses to the included organs and the ICRP 103 tissue weighting factors. The deviation between measured and simulated organ doses was between 3% and 24%. Reducing the protocol exposure time to half of its original value resulted in a reduction in the absorbed doses of the organs of 50%, while the reduced rotation range resulted in a dose reduction of at least 60%. Absorbed doses obtained from "Low dose thorax 10ms" protocol were higher than the doses from our departments orthogonal kV-kV imaging protocol. Doses acquired from "Under breast" protocol were comparable to the doses measured from the orthogonal kV-kV imaging protocol. The effective dose per fraction using the CBCT for standard low-dose thorax protocol was 5.00 ± 0.30 mSv; for the "Low dose thorax 10ms" protocol it was 2.44 ± 0.21 mSv; and for the "Under breast" protocol it was 1.23 ± 0.25 mSv when the image isocenter was positioned at the phantom center and 1.17 ± 0.30 mSv when the image isocenter was positioned in the middle of right breast. The effective dose per fraction using the orthogonal kV-kV protocol was 1.14 ± 0.16 mSv. The reduction of the scan exposure time or beam rotation range of the CBCT imaging significantly reduced the dose to the organs investigated. The doses from the "Under breast" protocol and orthogonal kV-kV imaging protocol were comparable. Simulated organ doses correlated well with measured doses. Effective doses from imaging techniques should be considered with the increase use of kV imaging protocols in order to support the use of IGRT.
锥形束计算机断层扫描(CBCT)用于外照射放射治疗的设置和靶区定位。与电离辐射的所有医学应用一样,应安全管理辐射暴露并进行优化,以使用尽可能低的剂量获得必要的图像质量。本研究调查了标准千伏(kV)射线照相和 CBCT 成像协议的剂量,并为接受外照射放射治疗的乳腺癌患者提出了两种新的降低剂量的 CBCT 协议。选择瓦里安 On-Board Imaging 系统上提供的标准胸部 kV 和低剂量胸部 CBCT 协议作为乳房成像的参考技术。通过修改低剂量胸部协议创建了两种新的 CBCT 协议,一种是减少机架旋转范围(“乳房下”协议),另一种是减少管电流-时间乘积设置(“低剂量胸部 10ms”协议)。在人体模型假体内使用 XRQA2 光致变色胶片测量肺、心脏、乳房和皮肤的吸收剂量。使用 PCXMC 蒙特卡罗模拟软件计算肺、心脏和乳房的吸收剂量。使用包括器官的测量剂量和 ICRP 103 组织权重因子计算有效剂量。器官剂量的测量值与模拟值之间的偏差在 3%到 24%之间。将协议曝光时间减少到其原始值的一半,可使器官吸收剂量降低 50%,而减少旋转范围可使剂量降低至少 60%。来自“低剂量胸部 10ms”协议的吸收剂量高于我们部门正交 kV-kV 成像协议的剂量。来自“乳房下”协议的剂量与从正交 kV-kV 成像协议测量的剂量相当。使用标准低剂量胸部协议的 CBCT 获得的每个部分的有效剂量为 5.00 ± 0.30 mSv;对于“低剂量胸部 10ms”协议,有效剂量为 2.44 ± 0.21 mSv;对于“乳房下”协议,当图像等中心位于体模中心时,有效剂量为 1.23 ± 0.25 mSv,当图像等中心位于右乳房中部时,有效剂量为 1.17 ± 0.30 mSv。使用正交 kV-kV 协议的有效剂量为 1.14 ± 0.16 mSv。CBCT 成像扫描曝光时间或光束旋转范围的减少显著降低了所研究器官的剂量。来自“乳房下”协议和正交 kV-kV 成像协议的剂量相当。模拟器官剂量与测量剂量密切相关。应考虑成像技术的有效剂量,以增加千伏成像协议的使用,以支持 IGRT 的使用。